Henlius Facts
  • 2010
    Founded in Shanghai
  • 2 Products
    Under NDA/MAA Review
  • 20+
    Candidates in R&D
  • First Launched
    Biosimilar in China
  • Global R&D Facilities
    Shanghai, Taipei and California
Comprehensive Platform
News
关于
複宏漢霖
生物技術
上海复宏汉霖生物技术股份有限公司由复星医药与海外科学家团队于2010年2月合资组建,公司主要致力于符合全球标准的生物类似药及创新型抗体药物的研发和生产。
A Galaxy of Talents
A Galaxy of Talents
共谋发展

In Henlius, employees are our most important resources and most valuable assets. Talents are top on our priorities.

We value talents by retaining them, developing them and putting right people to right place.